BusinessETST & Cannabis Therapeutics Inc. Announce its Cannabis Cannabinoid-Based Nutraceutical Patent & Generic Pharmaceutical Drug Timeline & Update.By Nasdaq OMXMar 6, 2017, 12:45 PM UTC
BusinessEarth Science Tech Inc. and Cannabis Therapeutics Inc. to hold High-Level R&D Strategy Session in Laval, Qc and announces Dr. Moutih Rafei, PhD, as a new member of the Advisory BoardBy Nasdaq OMXFeb 28, 2017, 1:00 PM UTC
BusinessEarth Science Tech Initiates its Cannabis Cannabinoid-Based Composition of its 2 New Pharmaceutical Drugs and 3 Nutraceutical Patent StudiesBy Nasdaq OMXFeb 23, 2017, 11:45 AM UTC
BusinessSurgical Oncologists and Oncology Health Care Professionals Come Together in Seattle to Discuss Groundbreaking Research and Advancements in the Surgical Treatment of CancerBy Nasdaq OMXFeb 15, 2017, 4:22 PM UTC
BusinessETST and its wholly owned subsidiary, Cannabis Therapeutics, Signs Joint Venture with Smart Medicines GMP for the Development of its Cannabis Cannabinoid-Based Drugs & NutraceuticalsBy Nasdaq OMXFeb 14, 2017, 12:15 PM UTC
BusinessEarth Science Tech Strengthens Advisory Board with Four Distinguished Scientists and Doctors to Expand the Pharmaceutical & Nutraceutical Development of Cannabinoids' Therapeutic Indications, R&D, Technology, IP and TreatmentsBy Nasdaq OMXFeb 9, 2017, 12:45 PM UTC
BusinessAlzheimer’s Foundation of America Calls on the Trump Administration to Increase Alzheimer’s Research SpendingBy Nasdaq OMXFeb 1, 2017, 5:31 PM UTC
